Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Lymphokine and Cytokine Research
|
February 1, 1993
Clones derived from human natural killer cells are susceptible to lysis by human interleukin-2-activated killer cells
T Fujiwara, W G Loudon, E A Grimm
Annals of the New York Academy of Sciences
|
January 1, 1988
Lymphokine-activated killer cells. Induction and function
E A Grimm, L B Owen-Schaub, W G Loudon, et al.
Cellular Immunology
|
January 1, 1988
Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors
L B Owen-Schaub, W G Loudon, M Yagita, et al.
Cancer Research
|
March 1, 1992
Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein)
J List, R P Moser, M Steuer, et al.
Surgical Neurology
|
November 17, 1998
Distribution of macromolecular dyes in brain using positive pressure infusion: a model for direct controlled delivery of therapeutic agents
S S Prabhu, W C Broaddus, G T Gillies, et al.
Journal of Neurosurgery
|
September 1, 1988
In vitro cytolysis of primitive neuroectodermal tumors of the posterior fossa (medulloblastoma) by lymphokine-activated killer cells
R E George, W G Loudon, R P Moser, et al.
Cancer Research
|
April 15, 1988
Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties
W G Loudon, S R Abraham, L B Owen-Schaub, et al.
Neurosurgery
|
October 8, 1997
Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells
W C Broaddus, Z J Chen, S S Prabhu, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype
E A Grimm, J M Bruner, J Carinhas, et al.
Journal of Neurosurgery
|
December 10, 1999
Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction
W C Broaddus, Y Liu, L L Steele, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Lymphokine and Cytokine Research
|
February 1, 1993
Clones derived from human natural killer cells are susceptible to lysis by human interleukin-2-activated killer cells
T Fujiwara, W G Loudon, E A Grimm
Annals of the New York Academy of Sciences
|
January 1, 1988
Lymphokine-activated killer cells. Induction and function
E A Grimm, L B Owen-Schaub, W G Loudon, et al.
Cellular Immunology
|
January 1, 1988
Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors
L B Owen-Schaub, W G Loudon, M Yagita, et al.
Cancer Research
|
March 1, 1992
Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein)
J List, R P Moser, M Steuer, et al.
Surgical Neurology
|
November 17, 1998
Distribution of macromolecular dyes in brain using positive pressure infusion: a model for direct controlled delivery of therapeutic agents
S S Prabhu, W C Broaddus, G T Gillies, et al.
Journal of Neurosurgery
|
September 1, 1988
In vitro cytolysis of primitive neuroectodermal tumors of the posterior fossa (medulloblastoma) by lymphokine-activated killer cells
R E George, W G Loudon, R P Moser, et al.
Cancer Research
|
April 15, 1988
Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties
W G Loudon, S R Abraham, L B Owen-Schaub, et al.
Neurosurgery
|
October 8, 1997
Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells
W C Broaddus, Z J Chen, S S Prabhu, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype
E A Grimm, J M Bruner, J Carinhas, et al.
Journal of Neurosurgery
|
December 10, 1999
Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction
W C Broaddus, Y Liu, L L Steele, et al.
Page
of 1